- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Celsion Corp (CBOA)
| Open: | 0.713 | Day's Range: | 0.713 - 0.805 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.762 | 52wk Range: | 0.546 - 7.202 | 1-Yr Rtn: | -46.19% |
Key Statistics for CBOA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.3900 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 5,345 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CBOA
Company Profile & Key Executives for CBOA
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
| Michael H TardugnoPresident/CEO | Timothy J TumminelloChief Acctg Officer/Controller |
| Gregory G Weaver "Greg"Senior VP/CFO | Jeffrey W Church "Jeff"Senior VP:Strategy & IR |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CBOA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page